Understanding how certain cells contribute to rheumatoid arthritis
Pathogenic fibroblast differentiation in rheumatoid arthritis
This study is looking at how certain signals in the body affect the cells that cause inflammation and damage in rheumatoid arthritis, with the hope of finding new ways to treat the condition and help patients feel better.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10890111 on NIH RePORTER |
What this research studies
This research investigates the role of Notch signaling in the differentiation of fibroblast cells that contribute to the inflammation and damage seen in rheumatoid arthritis. By using advanced techniques such as single-cell profiling and mouse models, the study aims to identify specific Notch receptors that drive the harmful changes in these cells. The ultimate goal is to explore whether targeting these receptors could lead to new treatments for arthritis, potentially improving patient outcomes. Patients may benefit from insights gained about the cellular mechanisms underlying their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rheumatoid arthritis who are experiencing significant joint inflammation.
Not a fit: Patients with other types of arthritis or those who do not have significant joint involvement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating rheumatoid arthritis.
How similar studies have performed: Previous research has shown promising results in targeting cellular pathways in arthritis, suggesting that this approach may yield beneficial outcomes.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Wei, Kevin S — Brigham and Women's Hospital
- Study coordinator: Wei, Kevin S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.